Address
Email address
Phone number
https://ntl.eeNordic Tersus LaboratoryNordic Tersus Laboratory OÜ pakub kõrgekvaliteedilisi mikrobioloogilisi uuringuid, hõlmates peamiselt desinfektsiooni- ja nahahooldusvahendite teste ja analüüse. Alates 2014 aastast omab Nordic Tersus Laboratory OÜ Eesti Akrediteerimiskeskuse poolt väljastatud akrediteerimistunnistust, mis vastab EN ISO/IEC 17025:2005 nõuetele kui katselabor mikrobioloogia analüüside valdkonnas. Nordic Tersus Laboratory OÜ teenindab kliente rahvusvaheliselt, pakkudes kvaliteetset meeskonda ja olles üks omanäolisemaid laboreid lähiregioonis.
Name
Nordic Tersus Laboratory OÜ
Registry code
12561442
VAT number
EE101714716
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
30.10.2013 (10)
Financial year
01.01-31.12
Capital
2 500.00 €
Activity
72191 - Other research and experimental development on natural sciences and engineering
145 415 €
3 058 €
2%
1 408 €
(estimate is approximate)
36 514 €
4
Submitted
No tax arrears
8%
6%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Ruth Oltjer 22.10.1959 (64) | 100% - 2 500.00 EUR | - | Direct ownership | Founder |
| Sander Piiskop 29.05.1985 (39) | - | Board member | - | |
| Aktsiaselts CHEMI-PHARM 10140819 | - | - | - | Founder |
| 2019 26.05.2020 | 2020 15.06.2021 | 2021 31.05.2022 | 2022 30.06.2023 | 2023 23.05.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 105 081 € | 130 109 € | 158 916 € | 136 951 € | 145 415 € |
| Net profit (loss) for the period | 8 725 € | 18 507 € | 17 721 € | -32 662 € | 3 058 € |
| Profit Margin | 8% | 14% | 11% | -24% | 2% |
| Current Assets | 6 886 € | 33 027 € | 45 123 € | 11 707 € | 21 580 € |
| Fixed Assets | 32 635 € | 30 768 € | 40 189 € | 37 623 € | 33 350 € |
| Total Assets | 39 521 € | 63 795 € | 85 312 € | 49 330 € | 54 930 € |
| Current Liabilities | 9 633 € | 15 400 € | 19 196 € | 15 874 € | 18 416 € |
| Non Current Liabilities | - | - | - | - | - |
| Total Liabilities | - | - | - | - | - |
| Share Capital | - | - | - | - | - |
| Equity | 29 888 € | 48 395 € | 66 116 € | 33 456 € | 36 514 € |
| Employees | 3 | 4 | 4 | 5 | 4 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 28 964.5 € | 12 245.75 € | 8 865.69 € | 2 |
| 2023 Q4 | 25 611 € | 8 909.85 € | 7 455.48 € | 2 |
| 2023 Q3 | 37 333.98 € | 15 657.15 € | 10 566.79 € | 2 |
| 2023 Q2 | 29 105.82 € | 12 254.68 € | 9 641.48 € | 3 |
| 2023 Q1 | 46 066.27 € | 10 329.85 € | 9 070.37 € | 3 |
| 2022 Q4 | 37 531.75 € | 17 381.67 € | 12 829.76 € | 3 |
| 2022 Q3 | 46 483.97 € | 19 786.59 € | 12 807.99 € | 4 |
| 2022 Q2 | 25 257.49 € | 13 034.41 € | 10 598 € | 4 |
| 2022 Q1 | 36 355 € | 9 336.07 € | 8 295.25 € | 4 |
| 2021 Q4 | 20 449 € | 8 707.24 € | 8 148.27 € | 3 |
| 2021 Q3 | 11 393 € | 8 939.52 € | 8 866.67 € | 3 |
| 2021 Q2 | 86 602.96 € | 23 375.03 € | 9 414.96 € | 3 |
| 2021 Q1 | 50 075.5 € | 12 366.3 € | 8 244.39 € | 4 |
| 2020 Q4 | 29 660 € | 9 359.45 € | 7 869.56 € | 5 |
| 2020 Q3 | 27 248 € | 10 050 € | 7 503.06 € | 5 |
| 2020 Q2 | 31 961.25 € | 8 460.81 € | 5 916.03 € | 5 |
| 2020 Q1 | 25 505.25 € | 9 399.89 € | 6 493.17 € | 4 |
